People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

“Melanin mellow-yellow,” she captioned the series of striking poses, sending fans into a frenzy over her trim figure and ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

Uagnda's Dei BioPharma Ltd has announced that the U.S. Food and Drug Administration has accepted the development plan for two of its novel biological drugs, liraglutide and semaglutide, which are used ...

Certain batches of injectable medicines, including insulin and weight-loss drugs, were reported stolen in transit. Experts ...

If you have hypoglycemia during Ozempic treatment, it’s possible that once your blood sugar is stable, the blurred vision will clear. If it doesn’t clear or you have any other vision problems that ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.

When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...

By Kami McDonald, Student Pharmacist and Karen L. Kier, Pharmacist ONU Healthwise Pharmacy ...